Resultado da Busca
Volume 25 , Issues 15, 2024. Current Drug Targets aims to cover developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. receptors, enzymes, genes.
- Publishing Ethics and Rectitude
Bentham is offering subject-based scholarly content...
- Increase Visibility of Your Article
Bentham is offering subject-based scholarly content...
- Editorial Board
He has published more than 200 scientific publications and...
- Current Drug Targets
Current Drug Targets - Current Drug Targets | Bentham...
- Most Accessed Articles
Most Accessed Articles - Current Drug Targets | Bentham...
- Open Access Articles
Open Access Articles - Current Drug Targets | Bentham...
- Reviewer Guidelines
Reviewer Guidelines - Current Drug Targets | Bentham Science
- Publishing Ethics and Rectitude
20 de fev. de 2024 · Table 1 Targeted drugs approved by the FDA and NMPA in 2023. Full size table. During the year, the FDA’s Centre for Drug Evaluation and Research (CDER) approved 55 novel drugs, surpassing 37...
Redirecting to https://www.eurekaselect.com/journal/13.
Current Drug Targets. ISSN: 1389-4501 (Print) eISSN: 1873-5592 (Online) Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.
Current Drug Targets aims to cover developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. receptors, enzymes, genes.
2 de abr. de 2024 · Ramona Curpan & Tudor I. Oprea. In 2023, 49 novel drugs (excluding vaccines and gene therapies) were approved for the first time in the United States, European Union and Japan. Of these, 40 have...
31 de mar. de 2022 · Novel drug targets in 2021. By. Sorin Avram, Liliana Halip, Ramona Curpan & Tudor I. Oprea. In 2021, regulatory agencies in the United States, European Union and Japan licensed 59 novel drugs...
